Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

(TEVA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Teva Pharmaceutical Up Over 13%, on Pace for Largest Percent Increase Since November 2018 -- Data Talk

07/28/2021 | 03:55pm EDT

Teva Pharmaceutical Industries Limited Sponsored ADR (TEVA) is currently at $10.14, up $1.23 or 13.73%

-- Would be highest close since June 28, 2021, when it closed at $10.25

-- On pace for largest percent increase since Nov. 1, 2018, when it rose 15.12%

-- Currently up two of the past three days

-- Up 2.47% month-to-date; on pace for best month since March 2021, when it rose 7.25%

-- Up 5.13% year-to-date

-- Down 85.91% from its all-time closing high of $72.00 on July 27, 2015

-- Down 14.39% from 52 weeks ago (July 29, 2020), when it closed at $11.85

-- Down 20.8% from its 52 week closing high of $12.81 on Feb. 9, 2021

-- Up 21.06% from its 52 week closing low of $8.38 on July 19, 2021

-- Traded as high as $10.30; highest intraday level since June 29, 2021, when it hit $10.36

-- Up 15.47% at today's intraday high; largest intraday percent increase since Oct. 21, 2019, when it rose as much as 19.33%

All data as of 3:36:23 PM

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

07-28-21 1554ET

All news about TEVA PHARMACEUTICAL INDUSTRIES LIMITED
02:10aGLAXOSMITHKLINE : Federal Circuit Vacates Judgment, Reinstates Jury's Verdict Of Induced I..
AQ
09/20IMMUNEERING : Announces Inclusion in the Russell 2000« Index
AQ
09/09TEVA PHARMACEUTICAL INDUSTRIES : - Late-Breaking Data at the International Headache Societ..
AQ
09/09IMMUNEERING CORP : Results of Operations and Financial Condition, Financial Statements and..
AQ
09/08TEVA PHARMACEUTICAL INDUSTRIES : Late-Breaking Data at the International Headache Society ..
BU
09/02IMMUNEERING : to Participate in September Investor Conferences
AQ
09/01GLOBAL MARKETS LIVE : Getlink, Intuit, CrowdStrike, Xiaomi, Merck...
09/01Health Care Stocks Inch Higher Ahead of Wednesday Open
MT
09/01MEDINCELL S A : Teva Eye US Launch Of Schizophrenia Therapy In 2022
MT
09/01TEVA PHARMACEUTICAL INDUSTRIES : MedinCell Schizophrenia Therapy Accepted For Review By US..
MT
More news
Analyst Recommendations on TEVA PHARMACEUTICAL INDUSTRIES LIMITED
More recommendations
Financials (USD)
Sales 2021 16 294 M - -
Net income 2021 1 074 M - -
Net Debt 2021 21 871 M - -
P/E ratio 2021 11,4x
Yield 2021 -
Capitalization 9 981 M 9 981 M -
EV / Sales 2021 1,95x
EV / Sales 2022 1,81x
Nbr of Employees 37 736
Free-Float 90,3%
Chart TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Duration : Period :
Teva Pharmaceutical Industries Limited Technical Analysis Chart | TEVA | US8816242098 | MarketScreener
Technical analysis trends TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 18
Last Close Price 9,05 $
Average target price 12,04 $
Spread / Average Target 33,0%
EPS Revisions
Managers and Directors
Kňre Schultz President, Chief Executive Officer & Director
Eli Kalif Chief Financial Officer & Executive Vice President
Sol J. Barer Chairman
Hafrun Fridriksdottir Executive VP-Global Research & Development
Eric DrapÚ Executive Vice President-Global Operations
Sector and Competitors
1st jan.Capi. (M$)
TEVA PHARMACEUTICAL INDUSTRIES LIMITED-6.22%9 981
JOHNSON & JOHNSON4.75%433 991
ROCHE HOLDING AG10.87%324 441
PFIZER, INC.19.40%247 760
NOVO NORDISK A/S51.58%233 750
ELI LILLY AND COMPANY37.51%210 490